Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research.
|
Glycobiology
|
2005
|
2.41
|
2
|
The Cenozoic palaeoenvironment of the Arctic Ocean.
|
Nature
|
2006
|
2.21
|
3
|
Data mining the protein data bank: automatic detection and assignment of carbohydrate structures.
|
Carbohydr Res
|
2004
|
1.89
|
4
|
Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB.
|
Nucleic Acids Res
|
2005
|
1.84
|
5
|
Impact Factors--The Bane of Our Existence.
|
Physiologist
|
2015
|
1.51
|
6
|
GlycomeDB--a unified database for carbohydrate structures.
|
Nucleic Acids Res
|
2010
|
1.46
|
7
|
Glycome-DB.org: a portal for querying across the digital world of carbohydrate sequences.
|
Glycobiology
|
2009
|
1.31
|
8
|
Bioinformatics for glycomics: status, methods, requirements and perspectives.
|
Brief Bioinform
|
2004
|
1.27
|
9
|
EUROCarbDB: An open-access platform for glycoinformatics.
|
Glycobiology
|
2010
|
1.13
|
10
|
Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum.
|
Biochem Pharmacol
|
2012
|
1.05
|
11
|
A structure-guided mutation in the major capsid protein retargets BK polyomavirus.
|
PLoS Pathog
|
2013
|
1.02
|
12
|
Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins.
|
Biochemistry
|
2003
|
1.02
|
13
|
The role of informatics in glycobiology research with special emphasis on automatic interpretation of MS spectra.
|
Biochim Biophys Acta
|
2005
|
1.01
|
14
|
Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems.
|
Eur J Health Econ
|
2015
|
1.00
|
15
|
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
|
Clin Ther
|
2011
|
0.96
|
16
|
STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core.
|
Glycobiology
|
2006
|
0.95
|
17
|
Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
|
Invest Radiol
|
2006
|
0.91
|
18
|
Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana.
|
FASEB J
|
2006
|
0.90
|
19
|
Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo.
|
Eur J Biochem
|
2004
|
0.90
|
20
|
Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains.
|
Protein Sci
|
2010
|
0.89
|
21
|
Structural basis for the recognition and cleavage of polysialic acid by the bacteriophage K1F tailspike protein EndoNF.
|
J Mol Biol
|
2010
|
0.86
|
22
|
The early Miocene onset of a ventilated circulation regime in the Arctic Ocean.
|
Nature
|
2007
|
0.84
|
23
|
Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.
|
J Biol Chem
|
2012
|
0.83
|
24
|
Impact factors: arbiter of excellence?
|
Physiologist
|
2002
|
0.83
|
25
|
Understanding the specificity of human Galectin-8C domain interactions with its glycan ligands based on molecular dynamics simulations.
|
PLoS One
|
2013
|
0.82
|
26
|
Molecular dynamics simulations of glycoclusters and glycodendrimers.
|
J Biotechnol
|
2002
|
0.81
|
27
|
Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15 mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin.
|
Chemistry
|
2005
|
0.81
|
28
|
Synthesis of cyclic beta-glucan using laminarinase 16A glycosynthase mutant from the basidiomycete Phanerochaete chrysosporium.
|
J Am Chem Soc
|
2010
|
0.80
|
29
|
Lewis histo-blood group α1,3/α1,4 fucose residues may both mediate binding to GII.4 noroviruses.
|
Glycobiology
|
2012
|
0.80
|
30
|
HIV-1 capsid assembly inhibitor (CAI) peptide: structural preferences and delivery into human embryonic lung cells and lymphocytes.
|
Int J Med Sci
|
2008
|
0.80
|
31
|
Adopting Quality Criteria for Websites Providing Medical Information About Rare Diseases.
|
Interact J Med Res
|
2016
|
0.79
|
32
|
Multiple blast extremity injuries: is definitive treatment achievable in a field hospital for local casualties?
|
Int Orthop
|
2014
|
0.79
|
33
|
Analysis of protein-carbohydrate interaction at the lower size limit of the protein part (15-mer peptide) by NMR spectroscopy, electrospray ionization mass spectrometry, and molecular modeling.
|
Biochemistry
|
2002
|
0.78
|
34
|
Interaction of the α2A domain of integrin with small collagen fragments.
|
Protein Cell
|
2010
|
0.78
|
35
|
A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC).
|
BMC Pulm Med
|
2014
|
0.78
|
36
|
An easily accessible sulfated saccharide mimetic inhibits in vitro human tumor cell adhesion and angiogenesis of vascular endothelial cells.
|
Beilstein J Org Chem
|
2012
|
0.77
|
37
|
Computation of binding energies including their enthalpy and entropy components for protein-ligand complexes using support vector machines.
|
J Chem Inf Model
|
2013
|
0.77
|
38
|
The structural basis of the difference in sensitivity for PNGase F in the de-N-glycosylation of the native bovine pancreatic ribonucleases B and BS.
|
Biochemistry
|
2008
|
0.76
|
39
|
Conformational analysis of the neutral exopolysaccharide produced by Lactobacillus delbrueckii ssp. bulgaricus LBB.B26.
|
Org Biomol Chem
|
2008
|
0.76
|
40
|
Comparative (1)H NMR and molecular modeling study of hydroxy protons of beta-D-Galp-(1-->4)-beta-D-GlcpNAc-(1-->2)-alpha-D-Manp-(1-->O)(CH(2))(7)CH(3) analogues in aqueous solution.
|
Carbohydr Res
|
2006
|
0.76
|
41
|
Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance.
|
Glycobiology
|
2011
|
0.76
|
42
|
Identification by high-throughput in silico screening of radio-protecting compounds targeting the DNA-binding domain of the tumor suppressor p53.
|
Cancer Genomics Proteomics
|
2013
|
0.75
|
43
|
Binding energy calculations for hevein-carbohydrate interactions using expanded ensemble molecular dynamics simulations.
|
J Comput Aided Mol Des
|
2014
|
0.75
|
44
|
Sensitivity analysis for dose deposition in radiotherapy via a Fokker-Planck model.
|
Math Med Biol
|
2017
|
0.75
|
45
|
The status of physiologists and physiology at US medical Schools.
|
Physiologist
|
2002
|
0.75
|
46
|
What's Past is Prologue.
|
Physiologist
|
2015
|
0.75
|
47
|
The more things change...
|
Physiologist
|
2011
|
0.75
|
48
|
Brillouin-scattering study of propylene carbonate: an evaluation of phenomenological and mode coupling analyses.
|
Phys Rev E Stat Nonlin Soft Matter Phys
|
2002
|
0.75
|
49
|
Free access for all! Can we afford it?
|
Physiology (Bethesda)
|
2006
|
0.75
|
50
|
Planning for the Future.
|
Physiologist
|
2016
|
0.75
|
51
|
APS: 125 years of progress of physiology as a scientific discipline and a profession.
|
Adv Physiol Educ
|
2013
|
0.75
|
52
|
Identification of a capsular polysaccharide from Moraxella bovis.
|
Carbohydr Res
|
2005
|
0.75
|
53
|
"Public access" to scientific literature?
|
FASEB J
|
2012
|
0.75
|
54
|
Nutritional insufficiency.
|
Physiologist
|
2014
|
0.75
|
55
|
Generalized Fokker-Planck theory for electron and photon transport in biological tissues: application to radiotherapy.
|
Comput Math Methods Med
|
2010
|
0.75
|
56
|
Porter Physiology Development Program 1967-2001: a retrospective study.
|
Physiologist
|
2004
|
0.75
|
57
|
A matter of opinion: "They're ba-aack!".
|
Physiologist
|
2014
|
0.75
|
58
|
Pyogenic sacroiliitis: diagnosis, management and clinical outcome.
|
Skeletal Radiol
|
2014
|
0.75
|
59
|
Editor's Note: AJP-Cell and AJP-Renal article series to honor the work of Dale Benos.
|
Am J Physiol Cell Physiol
|
2011
|
0.75
|
60
|
Merging departments: dealing with the good, the bad, and the ugly.
|
Physiologist
|
2009
|
0.75
|
61
|
We must do better!
|
Physiologist
|
2011
|
0.75
|